{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:11:31Z","timestamp":1777417891820,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.bbagen.2018.08.006","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T12:48:37Z","timestamp":1533559717000},"page":"2570-2578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Inhibition of amyloid fibril formation in the variable domain of \u03bb6 light chain mutant Wil caused by the interaction between its unfolded state and epigallocatechin-3-O-gallate"],"prefix":"10.1016","volume":"1862","author":[{"given":"Yoshito","family":"Abe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Odawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nantanat","family":"Aeimhirunkailas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hinako","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Fujisaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2018.08.006_bb0005","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1006\/jsbi.2000.4248","article-title":"Review: immunoglobulin light chain amyloidosis-the archetype of structural and pathogenic variability","volume":"130","author":"Bellotti","year":"2000","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0010","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.2174\/1568026611212220007","article-title":"Amyloid formation in light chain amyloidosis","volume":"12","author":"Ramirez-Alvarado","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0015","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1182\/blood.V99.12.4276","article-title":"Autologous stem cell transplantation for primary systemic amyloidosis","volume":"99","author":"Comenzo","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2018.08.006_bb0020","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1182\/blood-2004-08-3231","article-title":"The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis","volume":"105","author":"Palladini","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2018.08.006_bb0025","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3324\/haematol.11325","article-title":"Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone","volume":"92","author":"Kastritis","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.bbagen.2018.08.006_bb0030","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1182\/blood-2011-04-351643","article-title":"Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis","volume":"118","author":"Ward","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2018.08.006_bb0035","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jmb.2011.12.062","article-title":"Inhibition of amyloid formation","volume":"412","author":"H\u00e4rd","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bcp.2017.04.004","article-title":"Natural product-based amyloid inhibitors","volume":"139","author":"Velander","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0045","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1016\/j.bbagen.2013.06.029","article-title":"Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases","volume":"1830","author":"Cheng","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bbagen.2018.08.006_bb0050","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/pro.2228","article-title":"Mechanism for retardation of amyloid fibril formation by sugars in V\u03bb6 protein","volume":"22","author":"Abe","year":"2013","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0055","doi-asserted-by":"crossref","first-page":"e10935","DOI":"10.7554\/eLife.10935","article-title":"Inhibition by small-molecule ligands of formation of amyloid fibrils of an immunoglobulin light chain variable domain","volume":"4","author":"Brumshtein","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.bbagen.2018.08.006_bb0060","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1021\/bi0600749","article-title":"Small molecule inhibitors of alpha-synuclein filament assembly","volume":"45","author":"Masuda","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2018.08.006_bb0065","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.febslet.2011.03.046","article-title":"Inhibition and disaggregation of \u03b1-synuclein oligomers by natural polyphenolic compounds","volume":"585","author":"Caruana","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0070","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1074\/jbc.M408714200","article-title":"Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins","volume":"280","author":"Taniguchi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0075","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nsmb.1437","article-title":"EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers","volume":"15","author":"Ehrnhoefer","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0080","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1073\/pnas.0910723107","article-title":"EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity","volume":"107","author":"Bieschke","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0085","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/cphc.201700057","article-title":"Inhibitory mechanism of epigallocatechin gallate on fibrillation and aggregation of amidated human islet amyloid polypeptide","volume":"18","author":"Xu","year":"2017","journal-title":"ChemPhysChem"},{"key":"10.1016\/j.bbagen.2018.08.006_bb0090","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jmb.2012.01.013","article-title":"Structural properties of EGCG-induced, nontoxic Alzheimer's disease A\u03b2 oligomers","volume":"412","author":"Lopez Del Amo","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brainres.2008.02.107","article-title":"Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice","volume":"1214","author":"Rezai-Zadeh","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0100","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1182\/blood-2007-05-089243","article-title":"Epigallocathechin-3-gallate in AL amyloidosis: a new therapeutic option?","volume":"110","author":"Hunstein","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2018.08.006_bb0105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00392-008-0649-6","article-title":"Therapy effects of green tea in a patient with systemic light-chain amyloidosis","volume":"97","author":"Mereles","year":"2008","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0110","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00392-010-0142-x","article-title":"Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis","volume":"99","author":"Mereles","year":"2010","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0115","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12185-016-2112-1","article-title":"Phase 2 trial of daily, oral epigallocatechin gallate in patients with light-chain amyloidosis","volume":"105","author":"Meshitsuka","year":"2017","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0120","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1074\/jbc.M116.750323","article-title":"Aggregation of full-length immunoglobulin light chains from systemic light chain amyloidosis (AL) patients is remodeled by epigallocatechin-3-gallate","volume":"292","author":"Andrich","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0125","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1021\/acs.biochem.5b00288","article-title":"Inhibition of light chain 6aJL2-R24G amyloid Fiber formation associated with light chain amyloidosis","volume":"54","author":"Pelaez-Aguilar","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2018.08.006_bb0130","doi-asserted-by":"crossref","first-page":"41515","DOI":"10.1038\/srep41515","article-title":"Epigallocatechin-3-gallate preferentially induces aggregation of amyloidogenic immunoglobulin light chains","volume":"7","author":"Hora","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0135","doi-asserted-by":"crossref","first-page":"14101","DOI":"10.1021\/bi991131j","article-title":"Thermodynamic instability of human lambda 6 light chains: correlation with fibrillogenicity","volume":"38","author":"Wall","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2018.08.006_bb0140","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jmb.2009.07.078","article-title":"Residual structures in the acid-unfolded states of Vlambda6 proteins affect amyloid fibrillation","volume":"392","author":"Mishima","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0145","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/0003-2697(85)90607-4","article-title":"A convenient S-2-aminoethylation of cysteinyl residues in reduced proteins","volume":"149","author":"Okazaki","year":"1985","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0150","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1021\/ja0100120","article-title":"Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor","volume":"123","author":"Mayer","year":"2001","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0155","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1471-0307.2012.00873.x","article-title":"Studies on the interaction of (\u2212)-epigallocatechin-3-gallate from green tea with bovine \u03b2-lactoglobulin by spectroscopic methods and docking","volume":"66","author":"Wu","year":"2013","journal-title":"Int. J. Dairy Tech."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0160","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bbrc.2009.11.108","article-title":"Effects of His mutations on the fibrillation of amyloidogenic Vlambda6 protein Wil under acidic and physiological conditions","volume":"391","author":"Mishima","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0165","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0021-9258(17)35225-0","article-title":"Specific detection of quinoproteins by redox-cycling staining","volume":"266","author":"Paz","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0170","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/oxfordjournals.jbchem.a124606","article-title":"An S-alkylating reagent with positive charges as an efficient solubilizer of denatured disulfide-containing proteins","volume":"116","author":"Yamada","year":"1994","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0175","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/rcm.3985","article-title":"Systematic characterization of the covalent interactions between (\u2212)-epigallocatechin gallate and peptides under physiological conditions by mass spectrometry","volume":"23","author":"Cao","year":"2009","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0180","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.foodchem.2016.02.134","article-title":"Certain (\u2212)-epigallocatechin-3-gallate (EGCG) auto-oxidation products (EAOPs) retain the cytotoxic activities of EGCG","volume":"204","author":"Wei","year":"2016","journal-title":"Food Chem."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0185","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.freeradbiomed.2008.07.023","article-title":"Covalent modification of proteins by green tea polyphenol (\u2212)-epigallocatechin-3-gallate through autoxidation","volume":"45","author":"Ishii","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0190","doi-asserted-by":"crossref","first-page":"23212","DOI":"10.1074\/jbc.M113.464222","article-title":"Site-specific inhibitory mechanism for amyloid \u03b242 aggregation by catechol-type flavonoids targeting the Lys residues","volume":"288","author":"Sato","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0195","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1021\/jf971022g","article-title":"Stabilizing effect of ascorbic acid on green tea catechins","volume":"46","author":"Chen","year":"1998","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0200","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q","article-title":"Characterization of ligand binding by saturation transfer difference NMR spectroscopy","volume":"38","author":"Mayer","year":"1999","journal-title":"Angew. Chem. Intl. Ed."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0205","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1021\/acs.jmedchem.7b00428","article-title":"Insights on the interaction between transthyretin and a\u03b2 in solution. a saturation transfer difference (STD) NMR analysis of the role of iododiflunisal","volume":"60","author":"Gimeno","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0210","doi-asserted-by":"crossref","first-page":"14076","DOI":"10.1021\/acs.jpcb.5b07911","article-title":"Molecular level insights on collagen-polyphenols interaction using spin-relaxation and saturation transfer difference NMR","volume":"119","author":"Reddy","year":"2015","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bbagen.2018.08.006_bb0215","doi-asserted-by":"crossref","first-page":"18383","DOI":"10.1002\/chem.201503086","article-title":"How Epigallocatechin-3-gallate and tetracycline interact with the Josephin domain of Ataxin-3 and Alter its aggregation mode","volume":"21","author":"Bonanomi","year":"2015","journal-title":"Chemistry"},{"key":"10.1016\/j.bbagen.2018.08.006_bb0220","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1460-9568.2005.04532.x","article-title":"Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity","volume":"23","author":"Bastianetto","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0225","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1021\/ja3115696","article-title":"Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils","volume":"135","author":"Palhano","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0230","doi-asserted-by":"crossref","first-page":"13720","DOI":"10.1021\/jacs.7b05012","article-title":"Molecular mechanism for the (\u2212)-epigallocatechin gallate-induced toxic to nontoxic remodeling of A\u03b2 oligomers","volume":"139","author":"Ahmed","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0235","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1021\/bi100939a","article-title":"The flavanol (\u2212)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity","volume":"49","author":"Meng","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2018.08.006_bb0240","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1021\/acs.jpcb.7b01409","article-title":"Optimized ultrasonic irradiation finds out ultrastable A\u03b21\u201340 oligomers","volume":"121","author":"Nakajima","year":"2017","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bbagen.2018.08.006_bb0245","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1039\/C5SM02916C","article-title":"Shear-induced amyloid fibrillization: the role of inertia","volume":"12","author":"McBride","year":"2016","journal-title":"Soft Matter"},{"key":"10.1016\/j.bbagen.2018.08.006_bb0250","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.bpj.2008.11.042","article-title":"Agitation and high ionic strength induce amyloidogenesis of a folded PDZ domain in native conditions","volume":"96","author":"Sicorello","year":"2009","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0255","doi-asserted-by":"crossref","first-page":"32843","DOI":"10.1074\/jbc.M506501200","article-title":"Ultrasonication-induced amyloid fibril formation of beta2-microglobulin","volume":"280","author":"Ohhashi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0260","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.freeradbiomed.2007.04.008","article-title":"Autoxidative quinone formation in vitro and metabolite formation in vivo from tea polyphenol (\u2212)-epigallocatechin-3-gallate: studied by real-time mass spectrometry combined with tandem mass ion mapping","volume":"43","author":"Sang","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0265","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.phrs.2011.02.007","article-title":"The chemistry and biotransformation of tea constituents","volume":"64","author":"Sang","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0270","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bpc.2016.10.001","article-title":"Effects of oxidative post-translational modifications on structural stability and self-assembly of \u03bb6 immunoglobulin light chain","volume":"219","author":"Zottig","year":"2016","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0275","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1747-0285.2005.00318.x","article-title":"Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism","volume":"67","author":"Porat","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bbagen.2018.08.006_bb0280","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/13506129909007322","article-title":"Tertiarystructureof human lambda 6 light chains","volume":"6","author":"Pokkuluri","year":"1999","journal-title":"Amyloid"},{"key":"10.1016\/j.bbagen.2018.08.006_bb0285","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbapap.2016.01.009","article-title":"Probing the role of \u03bb6 immunoglobulin light chain dimerization in amyloid formation","volume":"1864","author":"Wolwertz","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2018.08.006_bb0290","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1021\/bi1004409","article-title":"The crystal structure of the green tea polyphenol (\u2212)-epigallocatechin gallate-transthyretin complex reveals a novel binding site distinct from the thyroxine binding site","volume":"49","author":"Miyata","year":"2010","journal-title":"Biochemistry"}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416518302472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416518302472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T03:54:35Z","timestamp":1759636475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416518302472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0304416518302472"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2018.08.006","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of amyloid fibril formation in the variable domain of \u03bb6 light chain mutant Wil caused by the interaction between its unfolded state and epigallocatechin-3-O-gallate","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2018.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}